Canadian Cannabis BPA estimée Q/Q
Quel est le BPA estimée Q/Q de Canadian Cannabis?
Le BPA estimée Q/Q de Canadian Cannabis Corp. est N/A
Quelle est la définition de BPA estimée Q/Q?
Le taux de croissance prospectif du BPA trimestriel, d'une année à l'autre , correspond à l'augmentation estimée du BPA d'une entreprise pour le prochain trimestre par rapport à la performance d'un trimestre précédent.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Que fait Canadian Cannabis?
Canadian Cannabis Corp. focuses on the manufacture and marketing of medical marijuana products in Canada and internationally. The company intends to offer 15 different strains of dried marijuana, as well as the constituents to produce edible and elixir products for medicinal use. The company was founded in 2014 and is based in Brampton, Canada.